Other studies [61] have shown that LIPI is an independent prognostic factor for chemotherapy in wild-type EGFR patients and for EGFR-TKI therapy in EGFR-mutated subsets, but not for squamous cell carcinoma. The gene discussed is EGFR; the disease is squamous cell carcinoma.